🇺🇸 FDA
Pipeline program

Safety Study to Compare the Gastrointestinal Tolerability of Oral Tegomil Fumarate and Dimethyl Fumarate (Tecfidera®) in Healthy Volunteers.

NXPTEGO/23/P1-4

Phase 1 other active

Quick answer

Safety Study to Compare the Gastrointestinal Tolerability of Oral Tegomil Fumarate and Dimethyl Fumarate (Tecfidera®) in Healthy Volunteers. for Multiple Sclerosis is a Phase 1 program (other) at Neuraxpharm Pharmaceuticals S.L. with 1 ClinicalTrials.gov record(s).

Program details

Company
Neuraxpharm Pharmaceuticals S.L.
Indication
Multiple Sclerosis
Phase
Phase 1
Modality
other
Status
active

Clinical trials